Basecamp Research, an AI-focused biotech startup partnered with Microsoft and Nvidia, is setting off on its most ambitious trek yet: To collect genetic sequences of

Basecamp Research’s Trillion Gene Atlas will bring together genomic data from millions of species to guide AI-powered design of new medicines.

Plus, news about Eledon, Sobi, Ovid and CytomX: 🗓️ Ionis updates prion disease study timelines: The California oligonucleotide powerhouse has pushed back the primary completion

Johnson & Johnson secured an FDA approval on Wednesday for a psoriasis pill it expects to become a megablockbuster. Regulators gave the green light to

Johnson & Johnson’s much-anticipated oral IL-23 drug, icotrokinra, has claimed FDA approval as Icotyde for first-line treatment of plaque psoriasis.